<SEC-DOCUMENT>0001144204-15-071265.txt : 20151216
<SEC-HEADER>0001144204-15-071265.hdr.sgml : 20151216
<ACCEPTANCE-DATETIME>20151216163255
ACCESSION NUMBER:		0001144204-15-071265
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20151216
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151216
DATE AS OF CHANGE:		20151216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		151291295

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v427127_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d)<BR>
of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event
reported): <B>December 16, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MEDIFAST, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 35%; padding: 0; text-decoration: underline; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Delaware</U></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 27%; padding: 0; text-decoration: underline; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>001-31573</U></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 35%; padding: 0; text-decoration: underline; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>13-3714405</U></B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Commission file number)</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(IRS Employer</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">of incorporation)</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Identification No.)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>3600 Crondall Lane, Owings
        Mills, Maryland</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of Principal Executive
        Offices)</P></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>21117</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Zip Code)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B><U>(410)-581-8042</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>N/A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Written
communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Soliciting
material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font: 10pt Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 8.01.</B></FONT></TD>
    <TD STYLE="width: 91%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other Events.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 16, 2015, Medifast, Inc. issued a press release
announcing the declaration of a cash dividend by the company&rsquo;s Board of Directors. The full text of the press release is
attached as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 9.01.</B></FONT></TD>
    <TD STYLE="width: 91%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Financial Statements and Exhibits.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Exhibits.</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 4%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">99.1</FONT></TD>
    <TD STYLE="width: 91%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Press release dated
    December 16, 2015 titled &ldquo;Medifast Announces Initiation of Quarterly Dividend&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">MEDIFAST,&nbsp;INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="width: 3%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Timothy Robinson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Timothy Robinson</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Chief Financial Officer</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated: December 16, 2015</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 0%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%; padding: 0; text-decoration: underline; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Exhibit No.</U></B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 17%; padding: 0; text-decoration: underline; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Description</U></B></FONT></TD>
    <TD STYLE="padding: 0; width: 62%; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">99.1</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Press Release dated December 16, 2015 titled &ldquo;Medifast Announces  Initiation of Quarterly Dividend&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v427127_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_001.jpg" ALT="Medifast, Inc." STYLE="height: 78px; width: 192px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Medifast, Inc. Announces Initiation of
Quarterly Dividend</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Company Declares Quarterly Cash Dividend
of $0.25 per Share</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">OWINGS MILLS, Md., Dec. 16, 2015 /PRNewswire/ -- Medifast, Inc.
(NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and
programs, announced today that its Board of Directors has authorized a dividend program under which it intends to pay a regular
quarterly cash dividend to its stockholders. The initial quarterly cash dividend of $0.25 per share is payable on February 10,
2016 to stockholders of record as of the close of business on December 28, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;The initiation of a quarterly dividend reflects the conviction
our Board of Directors and executive team have in the Company&rsquo;s ability to consistently generate cash,&rdquo; said Michael
C. MacDonald, Medifast Chairman and Chief Executive Officer. &ldquo;We remain committed to enhancing value for stockholders and
are very pleased to return excess capital to them through a quarterly cash dividend while we maintain our existing stock repurchase
program.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company expects to maintain a program of paying dividends
on a quarterly basis. However, the declaration of dividends in the future is subject to the discretion of the Medifast Board of
Directors, who will evaluate the Company&rsquo;s dividend program from time to time based on factors that it deems relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Medifast</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Medifast, Inc. (NYSE: MED) is a leading United States manufacturer
and provider of clinically proven and easy-to-use weight-loss and weight-maintenance products and programs. The company sells its
products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal
coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. Medifast was founded in 1980 and
is located in Owings Mills, Maryland. For more information, log onto www.MedifastNow.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MED-F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This release contains &quot;forward-looking&rdquo; statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934,
as amended, and the Private Securities Litigation Reform Act of 1995. These &ldquo;forward-looking&rdquo; statements are based
on present circumstances and on Medifast's predictions with respect to events that have not occurred, that may not occur, or that
may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements, including
the expected future payment of dividends and any statement of the plans and objectives of management for future operations and
forecasts of future growth and value, are not guarantees of future performance or results and involve risks and uncertainties that
could cause actual events or results to differ materially from the events or results described in the forward-looking statements.
Such forward-looking statements are made only as of the date of this release and Medifast assumes no obligation to update forward-looking
statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.85pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor Contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICR, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Katie Turner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(646) 277-1228</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !. , # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BN8U_Q+
MJ.@R-))I43V9;"3_ &@C/U 0XK ?XH,$.VQM@W;]](WZ".MHT*DE=(RE7A%V
M;/1J*\<\1_$V_N_#T@TR>*TO8YE\QXLD[.A&'&5.<=NF>:V(?B@8(+>&:.UF
MN$A7SW:9D+/CDX"D*,],G\JMX2K:]B%BJ=[7/2Z*\\7XI0D<V,'X7H_^)KKM
M%U*^U.$SW6F_8X64-$3.'+@^V!C\:SG1G!7DC2-6$W:+-6BBBLC0**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!" P((R",$5P/BCP-;I:3WVF"Z
M'EH\DEM%/)NEP,A4^;"Y/'0^U=_15TZDH.Z(G3C-69\WW.D:-<:;-<QO9V<J
M(K#RK]G<L74%6CD ;(!)R#VJW::%;PZM;V>FR+-=33^6LME?F64)_?;: H7N
M1G-=!XZL6T_7]7WZ7!J<NH)'<1S@XDM$5E7:01C!/&1SS73_  \LB]]K&KQV
M4.EP32"V.G1'/E21_>9N,!CGH.*]259JGS_UT/-C13J<IM>'O"4&D>7<W$TU
MQ?!<,QGD:,'_ &58FN/\<_$;7/"?B-]/@@L)X6C66-G1MP!['#>U>J5X7XOT
MO_A*/&?BR92^=*LE:/;TW+C(/X;JY,-:I4;J:HZL1>G32IZ,]<\+:U_PD/AJ
MQU0JBO/'F14/"L#@C\Q7*?$7XAW7A*]L[+3X;>:>5#)+YP)VKG Z$=>?RK-^
M"VLH_A_4-.F<+]CD\Y23T1AS^ (/YUQ?B.WD\2Z9K?C28N(S>I;6:YX\L<'^
MGXYK2GAXJNU+9?KL9U*\G03CN_TW/6?A]XCU;Q5I,NIZ@EI%#YABBC@5LDC&
M222:["O._A)<PVWPZ:>>18X8;B9G=CPH&"34>F>/]9\8:S<67ABQM8K6!=S7
M=\6.1G ^5?7TK&K1;J2Y59(VIU4J<>9W;/2**\WT_P")-Y8^+&\.>*+."WGW
MB-;FW8["3]TD'L<CFK'C+XGVWAS4/[+L+0W^H# ==V$0GH..2?85'U:IS**6
MY?UBGR\S>QU6O>)-,\-6T=QJDKQ0R-L5EC+#/7''2JK^+K&7PC<^(K".6[MH
M49E15*LY4X[UY[\2+CQ/<^!H)M:MM/M8GN8SY,+,TBG#8!)X^M:W@K4IM'^#
MAU&"".=[<2R>5(V P#'(S]*U^KQ5-2W=[&7MVZCCLK7-WP%XUD\9V=W+)8&U
M:W<+E7W*^0>AP.1CG\*WM:U[3/#UE]KU2[2WB)PN[DL?0 <FN8^''B^3Q5:W
M^=.MK)+9T"I!T.X$G/Y5YM\0KG4_$'Q%@T>40EH72""*-B5&X@Y/OR,_2G'#
MJ=9Q:Y4A.NX45):MGK5MXUM[H6DJ:3JPM;N18X;AK<!6+=#UR![D5T]<\]]K
M>F:=#&^EVUU=R2B&&&TD*QHN/O,S#@#'\JR?$NO>+O#VD2:JUCI,UO%@RQI)
M(60$XSD@ ]:Q]GS-*.GS-O:<JO+\CMZ*X_PWX^L]:\(W6NW<1M%LBPN$!W $
M 'Y?7.16;X7\=ZGXSOKM-.BT^RM[<C"W+,\L@.<$ 8';FE[":O=;;C]O#2SW
M/0JSY=;TV'5K?2WNXS?3YV0*<M@ DD@=!@=ZCL9]98745]9VRR1@&"6*4F.;
M.>H(RN#]>M>'>'IM5G^,,LL2VG]HM<S[@Y;RL[6SR.>G2KHT.?F;>R(JU^1Q
M26[/H6BJ]E]L-I']O$ N>=X@)*=>,9YZ58KF9T!1110!Y?\ &*!5MM,N]IW;
MGB8H_EL0<$ MTQQT/?GM75^ +86W@K3_ )0&E5I6..268G+'N<8R>]8_Q=A+
M^"C.!_J+A&)ZX!RO0\'DBNNT2 VNA6$!&#';HI .<?**ZIROAXKS9S1C^_D_
M(N2RI#"\LC!8T4LS'H .IKS3X6(FL?\ "3ZO*I;[?=E,G^[@G'Y,*[G7]%.O
M::]@U]<6L$H*R^1@,X],D<#Z5F>%_!</A(21V&HW3VTC;W@E"E2<8R.,CM^5
M1"48TI*^K*G&3J1=M$>"6\FJ>'M=U71K $SW6_3V3!RP+8&/?_&O5_&VBQ:%
M\&QIB8_T80AB.[[QN/XDFNHA\#Z/#XNG\2&-WO9,%58_)&V,%@/4U+XI\+1>
M*[-+.ZOKB&U#!FBAVC>PZ$DC/X5TSQ49S@]DK-F$,-*$)+OHCS+P5'<:G\'_
M !'IUH"TZ.Q55ZME5)'X@&J'PAAM[W4]0L9=0O+622-72.WF\OS0N<@GKQGL
M?6O3O#'@.W\)3R/IVI7ACE(,L,NUE?'3MP>>U,U3X:Z!J.H_VC +C3[W=O\
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MY/X3Z?::MX%UK3[[BVN+GRW^;!Y5<8/KG%4=1^"NJ6CM-HVK1RE>464&-_\
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MU=&]17 SZQJVDZEJKS);FZFFM82T63'$I1CN^8CGC') R12WGC'4;;38)O\
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MK#\+ZM-JMC,;F1'N(9-DFQ %' . 0Q##GJ#6Y6<HN+LRXR4E=!1112&%%%%
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9NQ60R*&*WC\N&)(TSG:B@#\A3Z**0S__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
